- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02871557
Frailty and the Elderly in Martinique (SAFMACohort)
August 15, 2016 updated by: Lidvine Godaert, Société Martiniquaise de Gérontologie et Gériatrie
Frail Elderly Subjects Martinique: Adverse Outcome After Hospitalisation in Geriatric Department
This was a prospective multicenter cohort study of elderly people admitted to the acute care for elders in Martinique.
They were followed up to 36 months.
It aimed to study the adverse outcomes.
In all, 287 subjects were included.
They were 85+/-6 years, and mainly women (61%).
Study Overview
Status
Completed
Detailed Description
The SAFMA cohort was an ad hoc study formed into the recruitment of the acute care for elders in the geriatric department of Martinique university Hospitals.
The inclusion of subjects ran from January 1st 2012 to June 30th 2012.
To be eligible, patients had to be 75 or over and hospitalised for acute condition.
Each patient was visited by a specialist in geriatrics familiar with the survey procedures.
In the course of this interview, patients were informed about the study, prior to signing the consent form.
If the clinical status and/or the cognitive status of the patient did not enable informed consent, the interviewer referred to the subject's representative.
Follow-up was performed by visits and telephone interview till 36 months.
Study Type
Observational
Enrollment (Actual)
287
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
75 years and older (Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
A group of elderly people hospitalised in acute care for elders
Description
Inclusion Criteria:
- Age of 75 years or over
- Admitted to acute care for elders
- Consent to participate
Exclusion Criteria:
- Impossibility to perform the tests
- Refusals to participate
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Mortality
Time Frame: 6 weeks
|
6 weeks
|
|
Nursing home admission
Time Frame: 6 weeks
|
6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Mortality
Time Frame: 6 month
|
6 month
|
|
Mortality
Time Frame: 12 month
|
12 month
|
|
Mortality
Time Frame: 24 month
|
24 month
|
|
Mortality
Time Frame: 36 month
|
36 month
|
|
Nursing home admission
Time Frame: 6 month
|
6 month
|
|
Nursing home admission
Time Frame: 12 month
|
12 month
|
|
Nursing home admission
Time Frame: 24 month
|
24 month
|
|
Nursing home admission
Time Frame: 36 month
|
36 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2012
Primary Completion (Actual)
January 1, 2012
Study Completion (Actual)
June 1, 2015
Study Registration Dates
First Submitted
August 11, 2016
First Submitted That Met QC Criteria
August 15, 2016
First Posted (Estimate)
August 18, 2016
Study Record Updates
Last Update Posted (Estimate)
August 18, 2016
Last Update Submitted That Met QC Criteria
August 15, 2016
Last Verified
August 1, 2016
More Information
Terms related to this study
Other Study ID Numbers
- 1958830
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.